A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19

NCT06965751 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Infection

Interventions

DRUG: PDI204
OTHER: 0.9 % saline

Sponsor

University of Melbourne

Collaborators

[object Object]
[object Object]